Welcome to finding the right path and a new you
What we know about Eli Lilly's orforglipron If all goes well for Lilly, orforglipron could be up for FDA approval for weight management by the end of 2025, and for type 2 diabetes treatment in 2026
Patients typically use it until they reach their weight-loss goals, then transition to lower maintenance doses or discontinue entirely
However, due to its short circulating half-life, native GLP-1 is ill-suited for chronic therapy [14]
Women of childbearing potential should use effective contraception during treatment and discuss with their healthcare provider if planning pregnancy, as tirzepatide should be discontinued at least 2 months before a planned pregnancy
Yes, you can eat normally about 6 to 8 weeks after a gastric bypass